Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Calumet Specialty Products Partners, L.P.CLMT · Entity 91042 | Director | May 07, 2024 | May 09, 2024 |
| Calumet, Inc. /DECLMT · Entity 3988 | Director | June 09, 2025 | June 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Calumet Specialty Products Partners, L.P.
Report date May 07, 2024 · Filed May 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom UnitSEC Table II · derivative / convertible security | Direct | 1,594 |
Reported balance
After 2024-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-07 · Grant · Acquired 1,594 · Balance 1,594 F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. |
| Phantom UnitsSEC Table II · derivative / convertible security | Direct | 531 |
Reported balance
After 2024-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-07 · Grant · Acquired 531 · Balance 531 F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit.
F2: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested.
F3: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025.
Calumet, Inc. /DE
Report date June 09, 2025 · Filed June 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,796 |
Reported balance
After 2025-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-09 · Grant · Acquired 3,796 · Balance 3,796 F1: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
F2: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2025 Filed Jun 12, 2025 00:15 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016774 · form4-06122025_120606.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,796 Underlying: Common Stock, par value $0.01 per share · 3,796 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:03 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | PurchaseCall Option (right to buy) · Derivative | 50 | $210.00 Strike: $18.00 | $10,500.00 |
DisclosureSEC source: 0001415889-25-015556 · form4-06042025_080659.xml · derivative · entry 4 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285 Underlying: Common Stock, par value $0.01 per share · 5,000 shares Expires 2026-01-16 Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:03 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | PurchaseCall Option (right to buy) · Derivative | 45 | $185.00 Strike: $18.00 | $8,325.00 |
DisclosureSEC source: 0001415889-25-015556 · form4-06042025_080659.xml · derivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235 Underlying: Common Stock, par value $0.01 per share · 4,500 shares Expires 2026-01-16 Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:03 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | PurchaseCall Option (right to buy) · Derivative | 100 | $160.00 Strike: $20.00 | $16,000.00 |
DisclosureSEC source: 0001415889-25-015556 · form4-06042025_080659.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190 Underlying: Common Stock, par value $0.01 per share · 10,000 shares Expires 2026-01-16 Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:03 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | PurchaseCall Option (right to buy) · Derivative | 90 | $143.00 Strike: $20.00 | $12,870.00 |
DisclosureSEC source: 0001415889-25-015556 · form4-06042025_080659.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90 Underlying: Common Stock, par value $0.01 per share · 9,000 shares Expires 2026-01-16 Read SEC document |
| May 06, 2025 Filed May 9, 2025 00:14 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Units · Derivative | 801 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012410 · form4-05092025_120557.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 801 Underlying: Common Stock, par value $0.01 per share · 801 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2026. F3 · derivative.expiration_date: Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2026. Read SEC document |
| May 06, 2025 Filed May 9, 2025 00:14 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 2,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012410 · form4-05092025_120557.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,403 Underlying: Common Stock, par value $0.01 per share · 2,403 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit will become settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 23:43 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Units · Derivative | 595 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005909 · form4-02272025_110205.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595 Underlying: Common Stock, par value $0.01 per share · 595 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2026. F3 · derivative.expiration_date: Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2026. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 23:43 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 1,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005909 · form4-02272025_110205.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,786 Underlying: Common Stock, par value $0.01 per share · 1,786 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit will be settled upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. Read SEC document |
| January 17, 2025 Filed Jan 21, 2025 22:43 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Units · Derivative | 66,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001815 · form4-01212025_100126.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 66,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. Read SEC document |
| January 17, 2025 Filed Jan 21, 2025 22:43 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 66,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001815 · form4-01212025_100126.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 394,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:35 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Units · Derivative | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028407 · form4-12052024_091209.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 8,921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: 100% of the Restricted Stock Units vested on November 3, 2024. F2 · derivative.expiration_date: 100% of the Restricted Stock Units vested on November 3, 2024. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:35 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028407 · form4-12052024_091209.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 14:40 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 4,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026505 · form4-11122024_021107.xml · derivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,935 Underlying: Common Stock, par value $0.01 per share · 4,935 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F4 · derivative.exercise_date: Restricted Stock Units vest on November 7, 2027. Restricted Stock Units will be settled upon vesting. F4 · derivative.expiration_date: Restricted Stock Units vest on November 7, 2027. Restricted Stock Units will be settled upon vesting. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 14:40 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Units · Derivative | 427 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026505 · form4-11122024_021107.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427 Underlying: Common Stock, par value $0.01 per share · 427 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2025. F3 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2025. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 14:40 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 1,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026505 · form4-11122024_021107.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,283 Underlying: Common Stock, par value $0.01 per share · 1,283 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 21:47 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Units · Derivative | 731 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021001 · form4-08082024_090851.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 731 Underlying: Common Stock, par value $0.01 per share · 731 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2025. F3 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Restricted Stock Units vest on July 1 of each year beginning on July 1, 2025. Read SEC document |
| August 06, 2024 Filed Aug 8, 2024 21:47 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 2,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021001 · form4-08082024_090851.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,195 Underlying: Common Stock, par value $0.01 per share · 2,195 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. F2 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Restricted Stock Units are 100% vested. Read SEC document |
| May 07, 2024 Filed May 9, 2024 15:44 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012712 · form4-05092024_070504.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531 Underlying: Common Units · 531 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025. Read SEC document |
| May 07, 2024 Filed May 9, 2024 15:44 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 1,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012712 · form4-05092024_070504.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,594 Underlying: Common Units · 1,594 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 14:33 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 506 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004993 · form4-02232024_070250.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506 Underlying: Common Units · 506 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2025. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 14:33 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 1,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004993 · form4-02232024_070250.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,518 Underlying: Common Units · 1,518 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 17:22 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 7,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014961 · form4-11092023_101114.xml · derivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,490 Underlying: Common Units · 7,490 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. F4 · derivative.expiration_date: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 17:22 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 649 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014961 · form4-11092023_101114.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 649 Underlying: Common Units · 649 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 17:22 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014961 · form4-11092023_101114.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,947 Underlying: Common Units · 1,947 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 17:46 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 583 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000065 · wf-form4_169109916084235.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 583 Underlying: Common Units · 583 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 17:46 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000065 · wf-form4_169109916084235.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Units · 1,750 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| May 02, 2023 Filed May 4, 2023 17:28 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000047 · wf-form4_168323568393208.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455 Underlying: Common Units · 455 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. Read SEC document |
| May 02, 2023 Filed May 4, 2023 17:28 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000047 · wf-form4_168323568393208.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,365 Underlying: Common Units · 1,365 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 17:11 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 401 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000013 · wf-form4_167719026786081.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401 Underlying: Common Units · 401 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2024. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 17:11 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000013 · wf-form4_167719026786081.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 Underlying: Common Units · 1,204 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 15:19 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 27,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000001 · wf-form4_167580117838536.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 27,855 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 100% of the Phantom Units vest on December 31, 2022. F2 · derivative.expiration_date: 100% of the Phantom Units vest on December 31, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 15:19 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 27,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000001 · wf-form4_167580117838536.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 17:51 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 2,000 | $15.70 | $31,400.00 |
DisclosureSEC source: 0001340122-22-000135 · wf-form4_166993507269357.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,283 Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 10:58 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 1,000 | $16.20 | $16,200.00 |
DisclosureSEC source: 0001340122-22-000134 · wf-form4_166982387758729.xml · nonDerivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,283 Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 10:58 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 1,000 | $16.15 | $16,150.00 |
DisclosureSEC source: 0001340122-22-000134 · wf-form4_166982387758729.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,283 Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 15:37 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 2,000 | $17.80 | $35,600.00 |
DisclosureSEC source: 0001340122-22-000132 · wf-form4_166871745769747.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,283 Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 10:28 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 1,000 | $17.70 | $17,700.00 |
DisclosureSEC source: 0001340122-22-000131 · wf-form4_166861249507494.xml · nonDerivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,283 Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 10:28 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 1,000 | $17.75 | $17,750.00 |
DisclosureSEC source: 0001340122-22-000131 · wf-form4_166861249507494.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,283 Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 14:22 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | PurchaseCommon Units | 2,000 | $18.00 | $36,000.00 |
DisclosureSEC source: 0001340122-22-000130 · wf-form4_166845372964713.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,283 Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:39 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 396 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000110 · wf-form4_166750794931594.xml · derivative · entry 3 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396 Underlying: Common Units · 396 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023. F4 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:39 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000110 · wf-form4_166750794931594.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,053 Underlying: Common Units · 5,053 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Phantom Units vest on November 1, 2025. Phantom Units will be settled upon vesting. F3 · derivative.expiration_date: Phantom Units vest on November 1, 2025. Phantom Units will be settled upon vesting. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:39 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000110 · wf-form4_166750794931594.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Underlying: Common Units · 1,187 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date.Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date.Phantom Units are 100% vested. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 16:23 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000080 · wf-form4_165964458648266.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,098 Underlying: Common Units · 582 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023 F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023 Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 16:23 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000080 · wf-form4_165964458648266.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,293 Underlying: Common Units · 1,745 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| May 03, 2022 Filed May 5, 2022 21:55 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 516 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000058 · wf-form4_165180212822566.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516 Underlying: Common Units · 516 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023. Read SEC document |
| May 03, 2022 Filed May 5, 2022 21:55 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 1,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000058 · wf-form4_165180212822566.xml · derivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,548 Underlying: Common Units · 1,548 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F2 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 09:36 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000038 · wf-form4_164675015422959.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 7,103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 09:36 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000038 · wf-form4_164675015422959.xml · nonDerivative · entry 1 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 17:56 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 535 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000020 · wf-form4_164574338350324.xml · derivative · entry 2 Carter James S · CIK 0001351915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535 Underlying: Common Units · 535 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023. F3 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.